Vertex Pharmaceuticals, Inc. (VRTX)
453.38
-0.36
(-0.08%)
USD |
NASDAQ |
Dec 31, 16:00
452.61
-0.77
(-0.17%)
After-Hours: 18:25
Vertex Pharmaceuticals Total Liabilities (Quarterly): 7.544B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Amgen, Inc. | 80.52B |
| Eli Lilly & Co. | 91.08B |
| IDEXX Laboratories, Inc. | 1.826B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.86B |
| Shareholders Equity (Quarterly) | 17.32B |
| Debt to Equity Ratio | 0.1059 |
| Current Ratio | 2.362 |
| Net Debt Paydown Yield | -0.18% |